ScaleSauce IPO Subscription Status – IPO Open

ScaleSauce IPO subscription status started on Friday December 5, 2025 and will close on December 9, 2025. ScaleSauce IPO to raise around ₹40.21 crores via IPO. The retail quota is 35%, QIB is 50% and NII is 15%. The price band is fixed at ₹101 to ₹107 per equity share.

Table of Contents

The ScaleSauce IPO minimum market lot is 2,400 shares with ₹2,56,800 application amount. The ScaleSauce IPO is a SME IPO, and it is to be listed on NSE SME.

Business Overview

Encompass Design India Limited (EDIL), founded in March 2010 and known as ‘ScaleSauce,’ builds and grows consumer brands in India. It focuses on home, living, and food products for modern urban consumers. One of the leading companies, Scale Sauce (Encompass Design India Limited), was founded in March 2010.

The Company’s core business activities include the manufacturing of home and lifestyle products, such as bed sheets, curtains, comforters, table linens, and pillow covers, as well as food products, with a primary focus on sauces, marketed under its own brands.


IPOWatch View

We recommend investors may apply for an IPO with Long-term Views. Investors should also look at the QIB, NII, and Retail numbers before investing.

ScaleSauce IPO Subscription Status – Day 1

CategoryDay 1Day 2Day 3
QIB0.000.000.00
NII0.000.000.00
RII0.000.000.00
Total0.000.000.00


ScaleSauce IPO Investor Categories

  • Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, and Mutual Funds
  • Non-Institutional Investors(NII): Individual Investors, NRIs, Companies, Trusts, etc
  • Retail Individual Investors (RII): Retail Individual Investors or NRIs
  • Employee (EMP): Eligible Employees
  • Others: Eligible Shareholders

ScaleSauce IPO Review and Rating

  • May Apply For Long-term View

ScaleSauce IPO Form

How to apply for the ScaleSauce IPO? You can apply for ScaleSauce IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the ScaleSauce IPO in the Invest section. The other option is you can apply for ScaleSauce IPO via IPO forms downloaded online. Check out the Asston Pharmaceuticals forms – Click IPO Forms blank IPO forms download, fill, and submit in your bank or with your broker.

ScaleSauce IPO Subscription Status FAQs:


When ScaleSauce IPO Subscription will start?

The IPO subscription starts on December 5, 2025 for QIB, NII, and Retail Investors.

How to subscribe ScaleSauce IPO?

You can go with ASBA and Non-ASBA options for a subscription. Go to your bank account and apply for IPO online via ASBA or download the form online or get the physical form and submit the filled form to your broker or bank.

How do I check live ScaleSauce IPO Subscription Numbers Today?

One can visit our portal for live IPO subscription numbers that we are updating hourly basis from the official websites. One can check the live subscription on official websites on the particular IPO page.

How to Apply the ScaleSauce IPO through Zerodha?

Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

How to Apply the ScaleSauce IPO through Upstox?

Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

How to Apply the ScaleSauce IPO through Paytm Money?

Log in to Paytm Money Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals ” Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Paytm Money.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *